Leo Bronfman is Head of Legal and Compliance for Advanced Accelerator Applications (AAA), a Novartis company. Prior to joining AAA in September 2018, Leo spent three years at Novartis Oncology, where he was Director, Pharmaceutical Counsel and then Executive Director, Senior Pharmaceutical Counsel where he supported business development and licensing, alliance management and compliance functions. Before Novartis Oncology, Leo held the position of Senior Corporate Counsel for Sandoz U.S., where his responsibilities included legal support for business development and licensing transactions, product-related mergers and acquisitions and technical operations. After graduating from law school and prior to joining Sandoz U.S., Leo practiced law as a mergers and acquisitions corporate associate at various top law firms in New York, where he advised public and private companies on mergers and acquisitions, complex licensing and collaboration transactions, as well as general commercial and finance transactions Leo holds a Juris Doctor degree magna cum laude from Fordham University School of Law, and holds a Bachelor of Science degree magna cum laude from Hunter College, City University of New York.